All Outcomes
Home COVID-19 treatment researchIota-carrageenanIota-carragee.. (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta


Supplementary Data — Iota-carrageenan for COVID-19: real-time meta analysis of 1 study

@CovidAnalysis, April 2024, Version 3V3
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Excluded Carvallo 100% 0.00 [0.00-0.02] cases 0/788 237/407 CT​1​ Improvement, RR [CI] Treatment Control CARR-COV-02 Figueroa (DB RCT) 80% 0.20 [0.05-0.78] symp. case 2/196 10/198 Iota-carrageenan COVID-19 outcomes April 2024 ​1​ CT: study uses combined treatment Favors carrageenan Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop